{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:21:29Z","timestamp":1791321689692,"version":"4.3.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijantimicag.2025.107499","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T11:52:08Z","timestamp":1743767528000},"page":"107499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Profiling of omadacycline resistance in clinical MRSA: A nationwide genomic survey and in vitro evolutionary analysis"],"prefix":"10.1016","volume":"66","author":[{"given":"Yiyi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiteng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemu","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeqiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunsong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107499_bib0001","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40265-020-01257-4","article-title":"Omadacycline: a novel oral and intravenous aminomethylcycline antibiotic agent","volume":"80","author":"Zhanel","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0002","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s40265-018-1015-2","article-title":"Omadacycline: first Global Approval","volume":"78","author":"Markham","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101147","article-title":"Mechanism of staphylococcal resistance to clinically relevant antibiotics","volume":"77","author":"Brdov\u00e1","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0004","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02262-18","article-title":"Antimicrobial activity of omadacycline tested against clinical bacterial isolates from hospitals in mainland China, Hong Kong, and Taiwan: results from the SENTRY Antimicrobial Surveillance Program (2013 to 2016)","volume":"63","author":"Carvalhaes","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0005","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12866-020-02019-8","article-title":"Antimicrobial activity of omadacycline in vitro against bacteria isolated from 2014 to 2017 in China, a multi-center study","volume":"20","author":"Xiao","year":"2020","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0006","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/jac\/dkad174","article-title":"Exploring the third-generation tetracycline resistance of multidrug-resistant livestock-associated methicillin-resistant Staphylococcus aureus ST9 across healthcare settings in China","volume":"78","author":"Chen","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0007","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cmi.2021.05.024","article-title":"Epidemiology, evolution and cryptic susceptibility of methicillin-resistant Staphylococcus aureus in China: a whole-genome-based survey","volume":"28","author":"Chen","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089235","article-title":"Whole genome analysis of a community-associated methicillin-resistant Staphylococcus aureus ST59 isolate from a case of human sepsis and severe pneumonia in China","volume":"9","author":"Qu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0009","unstructured":"EUCAST. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0, Available at http:\/\/www.eucast.org The European Committee on Antimicrobial Susceptibility Testing, 2021. Last accessed on 1 January 2021."},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0010","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2021"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0011","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jac\/dkz461","article-title":"Tandem amplification of the vanM gene cluster drives vancomycin resistance in vancomycin-variable enterococci","volume":"75","author":"Sun","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0012","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-4939-0554-6_12","article-title":"Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq","volume":"1151","author":"Deatherage","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0013","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00932-20","article-title":"Parallel evolution of Tobramycin resistance across species and environments","volume":"11","author":"Scribner","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0014","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/molbev\/msp077","article-title":"FastTree: computing large minimum evolution trees with profiles instead of a distance matrix","volume":"26","author":"Price","year":"2009","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0015","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/cid\/ciz395","article-title":"Microbiology and preclinical review of Omadacycline","volume":"69","author":"Karlowsky","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0016","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.3389\/fmicb.2019.02546","volume":"10","author":"Bai","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01703-21","article-title":"Activity of omadacycline in rat methicillin-resistant Staphylococcus aureus osteomyelitis","volume":"66","author":"Karau","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0018","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1080\/22221751.2022.2032373","article-title":"Methicillin-resistant Staphylococcus aureus in China: a multicentre longitudinal study and whole-genome sequencing","volume":"11","author":"Wang","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1043736","article-title":"In vitro antimicrobial activity and resistance mechanisms of the new generation tetracycline agents, eravacycline, omadacycline, and tigecycline against clinical Staphylococcus aureus isolates","volume":"13","author":"Zeng","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12866-024-03232-5","article-title":"High prevalence of ST5-SCCmec II-t311 clone of methicillin-resistant Staphylococcus aureus isolated from bloodstream infections in East China","volume":"24","author":"Zhan","year":"2024","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0021","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2165969","article-title":"Phylogenetic analysis and virulence characteristics of methicillin-resistant Staphylococcus aureus ST764-SCCmec II: an emerging hypervirulent clone ST764-t1084 in China","volume":"12","author":"Xiao","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0022","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/S0021-9258(18)49928-0","article-title":"Purification and characterization of Tet(M), a protein that renders ribosomes resistant to tetracycline","volume":"266","author":"Burdett","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.709327","article-title":"Emergence of a tet(M) variant conferring resistance to tigecycline in Streptococcus suis","volume":"8","author":"Yu","year":"2021","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0024","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jgar.2023.12.002","article-title":"The first tigecycline resistant Enterococcus faecium in Norway was related to tigecycline exposure","volume":"36","author":"Hegstad","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0025","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/jac\/dkv420","article-title":"Tigecycline resistance in clinical isolates of enterococcus faecium is mediated by an upregulation of plasmid-encoded tetracycline determinants tet(L) and tet(M)","volume":"71","author":"Fiedler","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0026","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijantimicag.2015.07.009","article-title":"Deletions in a ribosomal protein-coding gene are associated with tigecycline resistance in Enterococcus faecium","volume":"46","author":"Niebel","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0027","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.meegid.2018.09.025","article-title":"Tigecycline resistance caused by rpsJ evolution in a 59-year-old male patient infected with KPC-producing Klebsiella pneumoniae during tigecycline treatment","volume":"66","author":"He","year":"2018","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0028","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ijantimicag.2017.10.003","article-title":"First description of rpsJ and mepA mutations associated with tigecycline resistance in Staphylococcus aureus isolated from a cystic fibrosis patient during antibiotic therapy","volume":"50","author":"Haim","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106215","article-title":"In vitro activity of eravacycline and mechanisms of resistance in enterococci","volume":"56","author":"Boukthir","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106304","article-title":"Genetic changes associated with tigecycline resistance in Staphylococcus aureus in vitro-selected mutants belonging to different lineages","volume":"57","author":"Herrera","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0031","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/AAC.04174-14","article-title":"Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium","volume":"59","author":"Cattoir","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0032","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1128\/AAC.00547-15","article-title":"The ribosomal S10 protein is a general target for decreased tigecycline susceptibility","volume":"59","author":"Beabout","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0033","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1128\/AAC.49.10.4327-4334.2005","article-title":"High-level chromosomally mediated tetracycline resistance in Neisseria gonorrhoeae results from a point mutation in the rpsJ gene encoding ribosomal protein S10 in combination with the mtrR and penB resistance determinants","volume":"49","author":"Hu","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0034","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1073\/pnas.1216691110","article-title":"Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis","volume":"110","author":"Jenner","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2025.107499_bib0035","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00634-23","article-title":"Tigecycline resistance-associated mutations in the MepA efflux pump in staphylococcus aureus","volume":"11","author":"Huang","year":"2023","journal-title":"Microbiol Spectr"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925000561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925000561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T14:55:21Z","timestamp":1746543321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925000561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0924857925000561"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107499","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiling of omadacycline resistance in clinical MRSA: A nationwide genomic survey and in vitro evolutionary analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107499"}}